Eversense 365 is more affordable than you think
One payment. One Year. One CGM.
With insurance coverage, Eversense 365 is an affordable option for year-round continuous glucose monitoring.
Commercial Insurance
Eversense 365 is covered by most commercial health plans for people taking insulin1. You may qualify for additional savings with the Eversense PASS® Programs2.
Medicare
Medicare covers Eversense 365 for people taking insulin to treat diabetes3 . Other patients might also qualify.
Coverage Details
Insurance providers typically limit CGM coverage to people who take insulin.
If you’re on insulin, Eversense 365 is covered by most commercial health plans.1 This includes Aetna, Cigna, Elevance (formerly Anthem), Humana, United Healthcare, most Blue Cross Blue Shield plans - and many others. If your plan does not cover, we encourage you to contact your insurance provider to request an exception.
If you pre-qualify, your Eversense Expert can help with a free benefits check. With a commercial insurance plan, you may also be eligible for our Eversense PASS® programs for further savings!
Medicare covers Eversense 365 CGM for people with diabetes who take insulin. People who are not on insulin but experience low blood glucose events may also qualify.
To qualify for a Eversense 365 CGM with Medicare, you must:
- Have diabetes
- Take insulin or have a history of low blood glucose
- Have been trained to use a continuous glucose monitor as prescribed by your doctor
- Make routine visits with your doctor
*Not a guarantee of coverage and payment. A doctor’s prescription is required for Medicare coverage and patients must meet Medicare eligibility coverage criteria. Coverage and payment may be subject to coinsurance, deductible and patient eligibility requirements. Visit http://www.medicare.gov to learn more about Medicare plans and coverage.
Unfortunately, Eversense CGM Systems are not covered by Medicaid or Medi-Cal at this time.
Save with the Eversense PASS® programs
Pay as little as $199 for a full year3. That's like paying less than $1 per day!4
To learn more, click to get pre-qualified.
Frequently Asked Questions
If you have insurance, your out of pocket cost will vary depending on your coverage and plan. If interested & qualified, we'd run a benefit investigation with your insurance company to confirm the cost.
If you're on commercial insurance, we have the PASS program that means you could pay as low as $199 for a full year. This includes the cost of both CGM sensor and transmitter.*
If you don't have insurance, call us at (945) 221-9068 to discuss cash-pay options.
An Eversense Expert can help! After your eligibility is confirmed, we’ll answer any questions you may have, assist you in locating an Eversense Inserter nearby, and determine the cost based on your insurance. We’ll submit the claim to your insurance provider and work directly with your health care provider and a distribution partner to order your Eversense 365 CGM.
We will remain in contact with you via email every step of the way.
Yes, insurance may cover both the product (sensor and transmitter) and the insertion and removal procedures. However every situation is different, so we recommend you get in touch via our pre-qualify form and an Eversense Expert can confirm what insurance covers for you and what out-of-pocket costs you may have.
Download our discussion guide and bring it to your next appointment and talk to your doctor about how Eversense 365 may be a better fit for your diabetes management plan. We will work with you and your health care provider to manage your insurance claim.
Our pre-qualification form will ask you a few questions about your diabetes type, therapy and your current insurance provider - this will allow us to tell you what your insurance may cover for Eversense. Our Eversense Expert will then get in touch with you to confirm your details and submit the claim to your insurance provider and work directly with your health care provider and a distribution partner to order your Eversense 365 CGM.
Ready to understand
your costs?
Our team can verify your coverage, explain your out-of-pocket costs, and help you get started with Eversense 365.
1. Data on File. Senseonics. Policy Reporter (8/23/2024)
2. Offer does not apply to the insertion and removal procedures. The Eversense PASS Program has limitations on eligibility. See website (Eversense PASS Programs Terms and Conditions) for more details. Ascensia Diabetes Care/Senseonics Inc (effective January 1, 2026) reserves the right to change or terminate this program at any time without notice. The program benefit is capped per transaction. There may be instances in which patient out-of-pocket costs exceed what is detailed in the offer. Eversense E3 is not eligible for the Eversense PASS® Program.
3.Not a guarantee of coverage and payment. A doctor’s prescription is required for Medicare coverage and patients must meet Medicare eligibility coverage criteria. Coverage and payment may be subject to coinsurance, deductible and patient eligibility requirements. Visit http://www.medicare.gov to learn more about Medicare plans and coverage. For additional details, visit Eversense Cost & Insurance
4.There are no payment programs offered by Ascensia Diabetes Care/Senseonics Inc (effective January 1, 2026) for the Eversense PASS program.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-US-0059